Dove Medical Press is going to pusblish an Article Collection in the International Journal of Nanomedicine on “Unveiling the Potential of Nanobiomaterials: Pioneering Insights into Biomedical Engineering“, organized by Guest Advisor Dr. Narsimha Mamidi, University of Wisconsin-Madison, United States.
Nanobiomaterials (NBMs) are a class of materials that combine the principles of nanotechnology and biomaterials to create innovative solutions for various biomedical applications. They are designed and engineered at the nanoscale level, which typically involves working with materials and structures that range from 1 to 100 nanometers in size. The field of NBMs has gained significant attention in recent years due to its potential to revolutionize medicine and healthcare. NBMs have unique properties and interactions at the nanoscale that make them suitable for a wide range of applications in biology, medicine, and medical devices.
In this Article Collection, here will be colleted research devoted to the interaction between NBMs and tissue/cell, the effect of size, morphology, shape, and surface of NBMs on their toxicity, biocompatibility, immunogenicity, design of novel biodegradable and biocompatible NBMs, instrumentation, and technologies to analyze biocompatibility of NBMs and challenges to overcome the toxicity of NBMs. This exposure could potentially pave the way for exciting and innovative concepts of NBMs and provide game-changing solutions for several research areas, including tissue engineering, drug delivery, medical devices, biosensors, and other biomedical applications.
This topic covers several successful models of NBMs, including polymer-based NBMs, magnetic and gold nanoparticles, quantum dots, and inorganic-organic-based and carbon nanomaterials (CNMs)-based NBMs, used in biomedical engineering and biosensing applications. We are specifically emphasizing articles narrating the cell and NBMs interaction, toxicity and biocompatibility advancing protocol, structural-property relationship, degradation of NBMs, etc. Topics include but are not limited to:
- Biocompatibility Assessment of NBMs
- Designing NBMs with multiple functions for medical purposes.
- Developing drug delivery strategies using NBMs as carriers.
- Using in vitro/in vivo approaches to understand the biological effects of NBMs.
Overall, it is hoped that this Article Collection will facilitate the assembling of new collaborations and motivate new generations to engage in the engineering of NBMs for a wide range of applications.
https://www.dovepress.com/submit_step_1.php.
The manuscript submission deadline is 30 September 2024.
Please contact Haoyang Yi (Commissioning Editor) at haoyang.yi@taylorandfrancis.com with any queries regarding this Article Collection.
Guest advisor:
Dr. Narsimha Mamidi, University of Wisconsin-Madison
Dr. Narsimha Mamidi is now serving as Scientist-I at WiscNano, University of Wisconsin-Madison, Wisconsin, USA. His primary research focus revolves around pioneering the development of Nanoformulations for the co-delivery of drugs and genes, with a particular emphasis on cancer immunotherapy. His overarching objective is to advance the application of Nanoformulations for clinical use, revolutionizing the landscape of immunotherapy. This endeavor entails the creation of user-friendly drug delivery platforms tailored for a spectrum of cancer types, including but not limited to triple-negative breast cancer, lung cancer, liver cancer, brain cancer, and pancreatic cancer.